 The vaccine being tested in this study is Takedas Tetravalent Dengue Vaccine Candidate TDV. TDV is being tested to protect people against dengue fever. This study will look at safety and the amount of antibodies to dengue fever formed in people who are administered a high-dose of TDV HD-TDV compared to TDV. 